The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs)
Open accessAbstract
Iron is essential for many biological processes, including oxygen delivery, and its supply is tightly regulated. Hepcidin, a small peptide synthesized in the liver, is a key regulator of iron absorption and homeostasis in mammals. Hepcidin production is increased by iron overload and decreased by anemia and hypoxia; but the molecular mechanisms that govern the hepcidin response to these stimuli are not known. Here we establish that the von Hippel-Lindau/hypoxia-inducible transcription factor (VHL/HIF) pathway is an essential link between iron homeostasis and hepcidin regulation in vivo. Through coordinate downregulation of hepcidin and upregulation of erythropoietin and ferroportin, the VHL-HIF pathway mobilizes iron to support erythrocyte production.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In particular, HIF effects (via hepcidin) the mobilisation or iron and can cause the expression of inflammatory cytokines such as IL-1, IL-6 and TNF-α [2254-2256] under conditions (hypoxia) where superoxide and peroxide production are likely to be increased, and consequently increases sepsis (in that HIF-knockout mice are resistant to LPS-induced sepsis [2254,2255]).”
From Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases (2009) · cites this paper as [2254]
In the citing paper
“and several proteins induced by hypoxia such as hypoxia inducible factor-1 (HIF-1) or platelet derived growth factor BB (PDGF-BB) reduce hepcidin expression, thereby enhancing iron delivery for erythropoiesis (Peyssonnaux et al., 2007; Sonnweber et al., 2014).”
From The Role of Iron Regulation in Immunometabolism and Immune-Related Disease (2019) · cites this paper as Peyssonnaux et al., 2007
In the citing paper
“The von Hippel-Lindau/hypoxia-inducible transcription factor (HIF) system also appears to control hepcidin expression, with HIF1␣ acting as a repressor when it binds to the hepcidin promoter.109”
From Forging a field: the golden age of iron biology. (2008) · cites this paper as [109]
In the citing paper
“Experimental studies in cultured cells, in animal models and in human subjects have established that hepcidin production is O2-sensitive and involves the HIF pathway.”
From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [193]
In the citing paper
“Subsequent investigation revealed that Nrf2 and AP1 family transcription factors, in conjunction with transcriptional coactivator p300/CBP, are involved in the activation of the ARE (246, 302, 306, 307)”
From Intracellular iron transport and storage: from molecular mechanisms to health implications (2008) · cites this paper as [246]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S. N., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,836
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
Feder, J. N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D. A., Basava, A., Dormishian, F., Domingo, R., Ellis, M. C., Fullan, A., et al. (1996) · Nature Genetics · doi:10.1038/ng0896-399 · Cited by 3,664
Nemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., & Ganz, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420945 · Cited by 2,650 · cited 1×
“As Albumin-Cre/VHLflox/flox mice exhibit hepatic inflammation and steatosis (21) (Figure 2C), we examined levels of the proinflammatory cytokine IL-6, which is known to stimulate hepcidin expression and may contribute to the anemia of chronic inflammation (5).”
BackgroundDysmetabolic Hyperferritinemia: All Iron Overload Is Not Hemochromatosis
Makker, J. S., Hanif, A., Bajantri, B., & Chilimuri, S. S. (2015) · Case Reports in Gastroenterology · doi:10.1159/000373883 · Cited by 1,353
Tian, H., McKnight, S. L., & Russell, D. W. (1997) · Genes & Development · doi:10.1101/gad.11.1.72 · Cited by 1,351
HIF-1 and mechanisms of hypoxia sensing
Semenza, G. L. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00194-0 · Cited by 1,301
A Novel Mammalian Iron-regulated Protein Involved in Intracellular Iron Metabolism
Abboud, S., & Haile, D. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000713200 · Cited by 1,267
Nicolas, G., Bennoun, M., Devaux, I., Beaumont, C., Grandchamp, B., Kahn, A., & Vaulont, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151179498 · Cited by 1,233
Self-citationNicolas, G., Chauvet, C., Viatte, L., Danan, J. L., Bigard, X., Devaux, I., Beaumont, C., Kahn, A., & Vaulont, S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215686 · Cited by 1,214
Self-citation
Flagged first, then by citations
Research works printed but not linked: 4
- Gu, 1998, Gene Expr., 7, 205
- Wenger, 1997, Biol. Chem., 378, 609
- Mazure, 2002, Cancer Res., 62, 1158
- Brugnara, 1994, J. Lab. Clin. Med., 123, 660
Cited by
Sorted by citations
Items 201–300 of 637
Peng, T., Du, S.-Y., Son, M., & Diamond, B. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2106017118 · Cited by 67
The Role of Hepcidin in Iron Homeostasis and Anemia in Hemodialysis Patients
Eleftheriadis, T., Liakopoulos, V., Antoniadi, G., Kartsios, C., & Stefanidis, I. (2009) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2008.00532.x · Cited by 66
Kong, W.-N., Gao, G., & Chang, Y.-Z. (2014) · Cell & Bioscience · doi:10.1186/2045-3701-4-19 · Cited by 71
Role of hypoxia in progressive chronic kidney disease and implications for therapy
Shoji, K., Tanaka, T., & Nangaku, M. (2013) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000441049.98664.6c · Cited by 66
Advances in understanding the mechanisms of erythropoiesis in homeostasis and disease
Liang, R. H.-S., & Ghaffari, S. (2016) · British Journal of Haematology · doi:10.1111/bjh.14194 · Cited by 69
What can we learn from ineffective erythropoiesis in thalassemia?
Oikonomidou, P. R., & Rivella, S. (2017) · Blood Reviews · doi:10.1016/j.blre.2017.10.001 · Cited by 67
Potential role of iron in repair of inflammatory demyelinating lesions
Lee, N. J., Ha, S.-K., Sati, P., Absinta, M., Nair, G., Luciano, N. J., Leibovitch, E. C., Yen, C. C., Rouault, T. A., Silva, A. C., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci126809 · Cited by 67
Divalent metal transporter 1 is a hypoxia‐inducible gene
Qian, Z., Wu, X. M., Fan, M., Yang, L., Du, F., Yung, W., & Ke, Y. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22485 · Cited by 64
Molecular basis of iron-loading disorders
Darshan, D., Frazer, D. M., & Anderson, G. J. (2010) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399410001687 · Cited by 63
Iron transport & homeostasis mechanisms: their role in health & disease.
Nadadur, S. S., Srirama, K., & Mudipalli, A. (2008) · PubMed · Cited by 64
Schachtschneider, K. M., Liu, Y., Rund, L. A., Madsen, O., Johnson, R. W., Groenen, M. A. M., & Schook, L. B. (2016) · BMC Genomics · doi:10.1186/s12864-016-3216-y · Cited by 65
Self-citationEffects of an acute exercise bout on serum hepcidin levels
Domínguez, R., Sánchez-Oliver, A., Mata-Ordoñez, F., Feria-Madueño, A., Grimaldi-Puyana, M., López-Samanes, Á., & Pérez-López, A. (2018) · Nutrients · doi:10.3390/nu10020209 · Cited by 64
“Cell culture studies have found that the activation of the hypoxia-induced factors (HIF-1α and HIF-2α) suppress hepcidin activity, and increase the bioavailability of iron-stimulating erythropoiesis [122].”
BackgroundKnown and potential roles of transferrin in iron biology
Bartnikas, T. B. (2012) · BioMetals · doi:10.1007/s10534-012-9520-3 · Cited by 63
Therapeutic Advances in Regulating the Hepcidin/Ferroportin Axis
Hawula, Z. J., Wallace, D. F., Subramaniam, V. N., & Rishi, G. (2019) · Pharmaceuticals · doi:10.3390/ph12040170 · Cited by 62
Mima, A. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174583 · Cited by 63
Haemochromatosis: The bone and the joint
Guggenbuhl, P., Brissot, P., & Loréal, O. (2011) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2011.10.014 · Cited by 67
Laukka, T., Myllykoski, M., Looper, R., & Koivunen, P. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.06.048 · Cited by 69
Altered nutrient status reprograms host inflammation and metabolic health via gut microbiota
Golonka, R. M., Xiao, X., Abokor, A. A., Joe, B., & Vijay–Kumar, M. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108360 · Cited by 60
Isoda, M., Hanawa, H., Watanabe, R., Yoshida, T., Toba, K., Yoshida, K., Kojima, M., Otaki, K., Hao, K., Ding, L., et al. (2009) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.04.009 · Cited by 60
Liu, L., Yu, Z., Cheng, H., Mao, X., Sui, W., Deng, S., Wei, X., Lv, J., Du, C., Xu, J., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-77450-y · Cited by 59
Iron Regulatory Hormone Hepcidin Decreases in Chronic Heart Failure Patients With Anemia
Matsumoto, M., Tsujino, T., Lee‐Kawabata, M., Naito, Y., Akahori, H., Sakoda, T., Ohyanagi, M., Tomosugi, N., & Masuyama, T. (2010) · Circulation Journal · doi:10.1253/circj.cj-09-0663 · Cited by 59
Modulation of hepcidin to treat iron deregulation: potential clinical applications
Blanchette, N. L., Manz, D. H., Torti, F. M., & Torti, S. V. (2015) · Expert Review of Hematology · doi:10.1586/17474086.2016.1124757 · Cited by 59
Intestinal Hypoxia-inducible Factor-2α (HIF-2α) Is Critical for Efficient Erythropoiesis
Anderson, E. R., Xue, X., & Shah, Y. M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.238667 · Cited by 58
Skeletal muscle hemojuvelin is dispensable for systemic iron homeostasis
Chen, W., Huang, F. W., Renshaw, T. B. D., & Andrews, N. C. (2011) · Blood · doi:10.1182/blood-2010-12-327957 · Cited by 60
Hepcidin and iron metabolism: From laboratory to clinical implications
Franchini, M., Montagnana, M., & Lippi, G. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.07.003 · Cited by 60
Hepcidin: A Critical Regulator of Iron Metabolism during Hypoxia
Hintze, K. J., & McClung, J. P. (2011) · Advances in Hematology · doi:10.1155/2011/510304 · Cited by 61
p53 tumor suppressor and iron homeostasis
Zhang, J., & Chen, X. (2018) · FEBS Journal · doi:10.1111/febs.14638 · Cited by 59
Thalassaemia Intermedia: an Update
Taher, A. T., Musallam, K. M., & Cappellini, M. D. (2009) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2009.004 · Cited by 59
Anaemia, iron homeostasis and pulmonary hypertension: a review
Sonnweber, T., Pizzini, A., Tancevski, I., Löffler‐Ragg, J., & Weiß, G. (2020) · Internal and Emergency Medicine · doi:10.1007/s11739-020-02288-1 · Cited by 59
Chapter 6 Iron Homeostasis and Erythropoiesis
Wrighting, D. M., & Andrews, N. C. (2008) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(07)00006-3 · Cited by 59
Iron metabolism and management: focus on chronic kidney disease
Agarwal, A. K. (2021) · Kidney International Supplements · doi:10.1016/j.kisu.2020.12.003 · Cited by 57
Hypoxia inhibits hepcidin expression in HuH7 hepatoma cells via decreased SMAD4 signaling
Chaston, T. B., Matak, P., Pourvali, K., Srai, S. K., McKie, A. T., & Sharp, P. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00121.2010 · Cited by 55
Eckard, J., Dai, J., Wu, J., Jian, J., Yang, Q., Chen, H., Costa, M., Frenkel, K., & Huang, X. (2010) · Cancer Cell International · doi:10.1186/1475-2867-10-28 · Cited by 56
Misdistribution of iron and oxidative stress in chronic kidney disease
Nakanishi, T., Kuragano, T., Nanami, M., Nagasawa, Y., & Hasuike, Y. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.06.025 · Cited by 57
Chuvash polycythemia VHLR200W mutation is associated with down-regulation of hepcidin expression
Gordeuk, V. R., Miasnikova, G. Y., Sergueeva, A. I., Niu, X., Nouraie, M., Okhotin, D. J., Polyakova, L. A., Ammosova, T., Nekhai, S., Ganz, T., et al. (2011) · Blood · doi:10.1182/blood-2011-03-345512 · Cited by 51
Regulation of iron metabolism through GDF15 and hepcidin in pyruvate kinase deficiency
Finkenstedt, A., Bianchi, P., Theurl, I., Vogel, W., Witcher, D. R., Wroblewski, V. J., Murphy, A. T., Zanella, A., & Zoller, H. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07535.x · Cited by 51
Kucejová, B., Sunny, N. E., Nguyen, A. D., Hallac, R. R., Fu, X., Peña‐Llopis, S., Mason, R. P., DeBerardinis, R. J., Xie, X.-J., DeBose‐Boyd, R. A., et al. (2011) · Oncogene · doi:10.1038/onc.2010.587 · Cited by 51
A coumarin-based fluorescent probe for monitoring labile ferrous iron in living systems
Long, L., Wang, N., Han, Y., Huang, M., Yuan, X., Cao, S., Gong, A., & Wang, K. (2018) · The Analyst · doi:10.1039/c8an00556g · Cited by 50
Wenger, R. H., & Kurtz, A. (2011) · Comprehensive physiology · doi:10.1002/cphy.c100075 · Cited by 55
Function of the hemochromatosis protein HFE: Lessons from animal models
Pantopoulos, K. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.6893 · Cited by 49
Endocrine and Bone Complications inβ-Thalassemia Intermedia: Current Understanding and Treatment
Inati, A. C., Noureldine, M. H. A., Mansour, A. G., & Abbas, H. A. (2015) · BioMed Research International · doi:10.1155/2015/813098 · Cited by 52
Essential but toxic: Controlling the flux of iron in the body
Anderson, G. J., & Wang, F. (2011) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2011.05661.x · Cited by 51
Protein degradation and iron homeostasis
Thompson, J. W., & Bruick, R. K. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.02.003 · Cited by 49
Regulation of Fibroblast Growth Factor 23 by Iron, EPO, and HIF
Wheeler, J. A., & Clinkenbeard, E. L. (2019) · Current Molecular Biology Reports · doi:10.1007/s40610-019-0110-9 · Cited by 48
Hirota, K. (2020) · Biomedicines · doi:10.3390/biomedicines8020032 · Cited by 52
Sonnweber, T., Nairz, M., Theurl, I., Petzer, V., Tymoszuk, P., Haschka, D., Rieger, E., Kaessmann, B., Deri, M., Watzinger, K., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203396 · Cited by 47
Iron Metabolism and Iron Chelation in Sickle Cell Disease
Walter, P. B., Harmatz, P., & Vichinsky, E. P. (2009) · Acta Haematologica · doi:10.1159/000243802 · Cited by 45
Oxidative damage and genotoxicity biomarkers in transfused and untransfused thalassemic subjects
Ferro, E., Visalli, G., Civa, R., Rosa, M. A. L., Papa, G. R., Baluce, B., D’Ascola, D. G., Piraino, B., Salpietro, C. D., & Pietro, A. D. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.08.592 · Cited by 46
Gagliardo, B., Kubat, N. J., Faye, A., Jaouen, M., Durel, B., Deschemin, J., Canonne‐Hergaux, F., Sari, M., & Vaulont, S. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.09.018 · Cited by 45
Self-citationEmerging Roles of the Tumor Suppressor p53 in Metabolism
Yu, L., Wu, M. Y., Zhu, G., & Xu, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.762742 · Cited by 49
Treatment of erythropoietin deficiency in mice with systemically administered siRNA
Querbes, W., Bogorad, R. L., Moslehi, J., Wong, J., Chan, A. Y., Bulgakova, E., Kuchimanchi, S., Akinc, A., Fitzgerald, K., Koteliansky, V., et al. (2012) · Blood · doi:10.1182/blood-2012-04-423715 · Cited by 45
The Case for an Estrogen-iron Axis in Health and Disease
Hamad, M. A., Bajbouj, K., & Taneera, J. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0885-1677 · Cited by 47
Xu, C., Sun, R., Qiao, X., Xu, C., Shang, X., Niu, W., & Chao, Y. (2014) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2014.18.4.313 · Cited by 45
Iron Deficiency in Pulmonary Arterial Hypertension: A Deep Dive into the Mechanisms
Quatredeniers, M., Mendes‐Ferreira, P., Santos‐Ribeiro, D., Nakhleh, M. K., Ghigna, M., Cohen‐Kaminsky, S., & Perros, F. (2021) · Cells · doi:10.3390/cells10020477 · Cited by 45
Garcia-Rojas, E. Y. L., Villanueva, C., & Bond, R. A. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.709509 · Cited by 49
Burczyk, G., Cichoń, I., & Kołaczkowska, E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.864638 · Cited by 45
Iron Metabolism and Inflammatory Mediators in Patients with Renal Dysfunction
Matsuoka, T., Abe, M., & Kobayashi, H. H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073745 · Cited by 53
Garrido, P., Ribeiro, S., Fernandes, J. C., Vala, H., Bronze-da-Rocha, E., Rocha‐Pereira, P., Belo, L., Costa, E. M., Santos‐Silva, A., & Reis, F. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124048 · Cited by 44
Mehta, K. J., Coombes, J. D., Briones-Orta, M. A., Manka, P. P., Williams, R. L., Patel, V. B., & Syn, W. (2017) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2017.08.012 · Cited by 44
Nagy, A., Pethő, D., Gáll, T., Zavaczki, E., Nyitrai, M., Posta, J., Zarjou, A., Agarwal, A., Balla, G., & Balla, J. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2019.01584 · Cited by 44
Costa, D. L., Amaral, E. P., Andrade, B. B., & Sher, A. (2020) · Antioxidants · doi:10.3390/antiox9121205 · Cited by 44
The Role of the Hypoxia-Related Unfolded Protein Response (UPR) in the Tumor Microenvironment
Bartoszewska, S., Collawn, J. F., & Bartoszewski, R. (2022) · Cancers · doi:10.3390/cancers14194870 · Cited by 43
Roxadustat in the treatment of anaemia in chronic kidney disease
Vecchio, L. D., & Locatelli, F. (2017) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2018.1417386 · Cited by 43
Regulation of FGF23: Beyond Bone
Šimić, P., & Babitt, J. L. (2021) · Current Osteoporosis Reports · doi:10.1007/s11914-021-00703-w · Cited by 43
The Hypoxia-Inducible Factor–C/EBPα Axis Controls Ethanol-Mediated Hepcidin Repression
Anderson, E. R., Taylor, M. J., Xue, X., Martin, A. S., Moons, D. S., Omary, M. B., & Shah, Y. M. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00723-12 · Cited by 43
Spagnuolo, R. D., Recalcati, S., Tacchini, L., & Cairo, G. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01208.x · Cited by 42
RetractedEstablished and Emerging Concepts to Treat Imbalances of Iron Homeostasis in Inflammatory Diseases
Petzer, V., Theurl, I., & Weiß, G. (2018) · Pharmaceuticals · doi:10.3390/ph11040135 · Cited by 41
Kartikasari, A. E. R., Wagener, F. A. D. T. G., Yachie, A., Wiegerinck, E. T. G., Kemna, E., & Winkels, D. W. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00494.x · Cited by 41
Jacolot, S., Férec, C., & Mura, C. (2008) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2008.01.006 · Cited by 42
Hepcidin is a Potential Regulator of Iron Status in Chronic Kidney Disease
Tsuchiya, K., & Nitta, K. (2012) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.12001 · Cited by 42
Maintaining Mammalian Iron and Oxygen Homeostasis
Salahudeen, A. A., & Bruick, R. K. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05038.x · Cited by 41
Zhou, Y., Wang, Q., Yang, Q., Tang, J., Xu, C., Gai, D.-W., Chen, X., & Chen, J. (2018) · Virologica Sinica · doi:10.1007/s12250-018-0057-7 · Cited by 41
Hepcidin as a therapeutic target for anemia and inflammation associated with chronic kidney disease
Małyszko, J., Małyszko, J. S., & Matuszkiewicz‐Rowińska, J. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1599358 · Cited by 40
Yan, Z., & Xu, G. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00393 · Cited by 40
Activated macrophages induce hepcidin expression in HuH7 hepatoma cells
Matak, P., Chaston, T. B., Chung, B., Srai, S. K., McKie, A. T., & Sharp, P. (2009) · Haematologica · doi:10.3324/haematol.2008.003400 · Cited by 40
Unraveling Mechanisms Regulating Systemic Iron Homeostasis
Finberg, K. E. (2011) · Hematology · doi:10.1182/asheducation-2011.1.532 · Cited by 41
Advancements in anemias related to chronic conditions
Guidi, G. C., & Santonastaso, C. L. (2010) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2010.264 · Cited by 39
Hare, G. M. T., Han, K., Leshchyshyn, Y., Mistry, N., Kei, T., Dai, S. Y., Tsui, A. K. Y., Pirani, R. A., Honavar, J., Patel, R. P., et al. (2018) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-018-1140-0 · Cited by 39
Camberlein, E., Zanninelli, G., Détivaud, L., Lizzi, A. R., Sorrentino, F., Vacquer, S., Troadec, M., Angelucci, E., Abgueguen, E., Loréal, O., et al. (2007) · Haematologica · doi:10.3324/haematol.11656 · Cited by 39
Inverse Correlation between IL-10 and HIF-1α in Macrophages Infected with Histoplasma capsulatum
Fecher, R. A., Horwath, M. C., Friedrich, D., Rupp, J., & Deepe, G. S. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600342 · Cited by 38
Miao, M., Wu, M., Li, Y., Zhang, L., Jin, Q., Fan, J., Xu, X., Gu, R., Hao, H., Zhang, A., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.837249 · Cited by 41
Insight onto the Pathophysiology and Clinical Complications of Thalassemia Intermedia
Cappellini, M. D., Musallam, K. M., & Taher, A. T. (2009) · Hemoglobin · doi:10.3109/03630260903351528 · Cited by 38
Iron: The new advances in therapy
Auerbach, M., Goodnough, L. T., & Shander, A. (2013) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2012.12.001 · Cited by 37
When less is more: novel mechanisms of iron conservation
Bayeva, M., Chang, H., Wu, R., & Ardehali, H. (2013) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2013.07.003 · Cited by 38
Association of hepcidin promoter c.-582 A>G variant and iron overload in thalassemia major
Andreani, M., Radio, F. C., Testi, M., Bernardo, C. D., Troiano, M., Majore, S., Bertucci, P., Polchi, P., Rosati, R., & Grammatico, P. (2009) · Haematologica · doi:10.3324/haematol.2009.006270 · Cited by 36
Salama, S. A., Omar, H. A., Maghrabi, I. A., AlSaeed, M. S., & El-Tarras, A. E. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.10.034 · Cited by 36
Hypoxia enhances H2O2-mediated upregulation of hepcidin: Evidence for NOX4-mediated iron regulation
da Silva, I. P., Rausch, V., Peccerella, T., Millonig, G., Seitz, H. K., & Mueller, S. (2018) · Redox Biology · doi:10.1016/j.redox.2018.02.005 · Cited by 35
Kober, K. M., Lee, M.-C., Olshen, A. B., Conley, Y. P., Sirota, M., Keiser, M. J., Hammer, M. J., Abrams, G., Schumacher, M. A., Levine, J. D., et al. (2020) · Molecular Pain · doi:10.1177/1744806920936502 · Cited by 35
Hanudel, M. R., Wong, S. F., Jung, G., Qiao, B., Gabayan, V. R., Zuk, A., & Ganz, T. (2021) · Kidney International · doi:10.1016/j.kint.2021.03.019 · Cited by 38
Fretham, S. J. B., Carlson, E. S., & Georgieff, M. (2013) · Journal of Nutrition · doi:10.3945/jn.112.168617 · Cited by 36
Bajbouj, K., Shafarin, J., Allam, H., Madkour, M. I., Awadallah, S. M., El-Serafi, A. T., Sandeep, D., & Hamad, M. A. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0043-124077 · Cited by 36
Regulation of iron homeostasis: Lessons from mouse models
Altamura, S., Marques, O., Colucci, S., Mertens, C., Alikhanyan, K., & Muckenthaler, M. U. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100872 · Cited by 35
Sardo, U., Perrier, P., Cormier, K., Sotin, M., Personnaz, J., Medjbeur, T., Desquesnes, A., Cannizzo, L., Ruíz-Martínez, M., Thevenin, J., et al. (2024) · Blood · doi:10.1182/blood.2023022724 · Cited by 36
Self-citationHypophosphatemic Rickets: Revealing Novel Control Points for Phosphate Homeostasis
White, K. E., Hum, J. M., & Econs, M. J. (2014) · Current Osteoporosis Reports · doi:10.1007/s11914-014-0223-2 · Cited by 34
Influence of post-exercise hypoxic exposure on hepcidin response in athletes
Badenhorst, C. E., DAWSON, B. T., Goodman, C., Sim, M., Cox, G. R., Gore, C. J., Tjalsma, H., Swinkels, D. W., & Peeling, P. (2014) · European Journal of Applied Physiology · doi:10.1007/s00421-014-2829-6 · Cited by 35
Ghoti, H., Fibach, E., Westerman, M. E., Olbina, G., Ganz, T., & Rachmilewitz, E. A. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08587.x · Cited by 33
Regulation of Iron Absorption in Hemoglobinopathies
Rechavi, G., & Rivella, S. (2008) · Current Molecular Medicine · doi:10.2174/156652408786241401 · Cited by 32
Guo, C., Han, X., Guo, T., Zhang, W., Xuan, W.-Q., Ren, Y.-T., Wang, D., Chen, Y.-H., Meng, Y., Gao, H., et al. (2020) · Food & Function · doi:10.1039/d0fo00910e · Cited by 33
Association of Serum Hepcidin Levels with Aerobic and Resistance Exercise: A Systematic Review
Larsuphrom, P., & Latunde-Dada, G. O. (2021) · Nutrients · doi:10.3390/nu13020393 · Cited by 37
New and old players in the hepcidin pathway
Camaschella, C., & Silvestri, L. (2008) · Haematologica · doi:10.3324/haematol.13724 · Cited by 33
Metadata
- Authors
- Peyssonnaux, C., Zinkernagel, A. S., Schuepbach, R. A., Rankin, E., Vaulont, S., Haase, V. H., Nizet, V., & Johnson, R. S.
- Affiliations
- University of California San Diego (US)
- Scripps Research Institute (US)
- University of Pennsylvania (US)
- Centre National de la Recherche Scientifique (FR)
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2007-07-02
- Volume
- 117
- Issue
- 7
- Pages
- 1926-1932
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1884690
- OpenAlex
- W2116374020
- Cited by
- 639
- References
- 36
- Citations by year
- 2026: 14 · 2025: 17 · 2024: 19 · 2023: 25 · 2022: 26 · 2021: 34 · 2020: 32 · 2019: 18 · 2018: 36 · 2017: 28 · 2016: 31 · 2015: 30 · 2014: 35 · 2013: 39 · 2012: 43
- FWCI
- 33.22
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- National Institutes of Health
- National Cancer Institute (R01CA100787)
- National Institute of Allergy and Infectious Diseases (AI060840, R01AI060840)
- National Institute of Diabetes and Digestive and Kidney Diseases (R21DK073467)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Keywords
- iron homeostasis, hypoxia-inducible factor, VHL, hepcidin, erythropoietin, ferroportin, iron mobilization, erythropoiesis, anemia, iron overload, hypoxia
- MeSH terms
- Ferroportin, Albumins, Animals, Base Sequence, Homeostasis, Humans, Iron, Liver, Mice, Inbred C57BL, Mice, Transgenic, Molecular Sequence Data, Polycythemia, Promoter Regions, Genetic, Protein Binding, Down-Regulation, Up-Regulation, Gene Deletion, Integrases, Hepatocytes, Antimicrobial Cationic Peptides, Cation Transport Proteins, Mice, Hypoxia-Inducible Factor 1, Von Hippel-Lindau Tumor Suppressor Protein, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
